CSIMarket
 
Curis Inc   (NASDAQ: CRIS)
 

Curis Inc's Suppliers Performance

CRIS's Supply Chain




 
CRIS Costs vs Sales of Suppliers Growth

• More on CRIS Suppliers






Curis Inc's Comment on Supply Chain


Starting materials for the drug substance are sourced from qualified suppliers, with production conducted under the company's supervision. Redundant suppliers are added as needed to ensure availability of key materials. Drug substance and drug product production, packaging, labeling, and distribution occur at multiple locations under GMP controls.

Curis Inc's Comment on Supply Chain


Starting materials for the drug substance are sourced from qualified suppliers, with production conducted under the company's supervision. Redundant suppliers are added as needed to ensure availability of key materials. Drug substance and drug product production, packaging, labeling, and distribution occur at multiple locations under GMP controls.







CRIS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Curis Inc 1.77 11.65 -21.15 24
SUBTOTAL 0.00 0.00 0.00 -


Sources: Curis Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Curis Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.